Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Ketotifen effectively prevents mucosal damage in experimental colitis
R. Eliakim
*
, F. Karmeli
,
E. Okon
, D. Rachmilewitz
*
Corresponding author for this work
Hadassah University Medical Centre
Research output
:
Contribution to journal
›
Article
›
peer-review
64
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ketotifen effectively prevents mucosal damage in experimental colitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acetic Acid
50%
Acetic Acid-induced Colitis
25%
Colitis
25%
Experimental Colitis
100%
Inflammatory Bowel Disease
25%
Inflammatory Response
25%
Intragastric Administration
25%
Ketotifen
100%
Leukotriene B4 (LTB4)
50%
LTC4
50%
Mast Cell Stabilizer
25%
Mechanism of Action
25%
Mucosal Damage
100%
Myeloperoxidase Activity
50%
Platelet-activating Factor
50%
Prostaglandin E2
50%
Thromboxane B2 (TXB2)
50%
Trinitrobenzene Sulfonic Acid
50%
Twice Daily
25%
Pharmacology, Toxicology and Pharmaceutical Science
2,4,6-Trinitrobenzenesulfonic Acid
50%
Colitis
50%
Experimental Colitis
100%
Histamine Release Inhibitor
25%
Inflammation
25%
Inflammatory Bowel Disease
25%
Ketotifen
100%
Leukotriene B4
50%
Leukotriene C4
50%
Myeloperoxidase
50%
Potassium Acetate
75%
Prostaglandin E2
50%
Thrombocyte Activating Factor
50%
Thromboxane B2
50%